Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …

Importance Since licensure of the human papillomavirus (HPV) vaccine in 2006, HPV
vaccine coverage among US adolescents has increased but remains low compared with …

Abstract Problem/Condition: Adults are at risk for illness, hospitalization, disability and, in
some cases, death from vaccine-preventable diseases, particularly influenza and …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Abstract The American Cancer Society (ACS) presents an adaptation of the current Advisory
Committee on Immunization Practices recommendations for human papillomavirus (HPV) …

Abstract Background The American Cancer Society (ACS), the Centers for Disease Control
and Prevention (CDC), the National Cancer Institute (NCI), and the North American …

Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

To evaluate receipt of≥ 1 dose of HPV vaccine by age 13 years among adolescent girls,
data during 2007–2013 NIS-Teen survey years were combined and analyzed by birth …

This report provides recommendations developed collaboratively by CDC and the Office of
Population Affairs (OPA) of the US Department of Health and Human Services (HHS). The …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
diseases (STDs) were updated by CDC after consultation with a group of professionals …